{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["1998"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2003609"],"study_start_month":["9"],"keyword":["Recurrent rectal cancer","Recurrent colon cancer","Stage IV rectal cancer","Eniluracil","Stage III rectal cancer","Stage I colon cancer","Stage I rectal cancer","Stage II colon cancer","Stage IV colon cancer","Stage III colon cancer","Stage II rectal cancer"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer","description":"RATIONALE: Eniluracil may increase the effectiveness of chemotherapy by blocking tumor enzymes that break down chemotherapy drugs.\nPURPOSE: Randomized phase II trial to determine the effectiveness of eniluracil followed by surgery in treating patients who have primary or metastatic colorectal cancer.","dates":{"creation":"1998-09-15"},"accession":"2003609","cross_references":{"ClinicalTrials___gov":["NCT00004195"]}}